Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention

NCT03098186 is registered in ClinicalTrials.gov with Fundación Cardiovascular de Colombia as lead sponsor.

NCT NCT03098186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03098186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TXT2HEART COLOMBIA: Evaluation of the Efficacy and Safety of Text Messages to Improve Adherence to Cardiovascular Medications in Secondary Prevention
Lead sponsor
Fundación Cardiovascular de Colombia
Phase
Not applicable
Overall status
Completed
Start date
April 18, 2017
Completion date
August 19, 2019
Enrollment
930 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease